Virtual Seminar – Bernadette Gillick, PhD, MSPT, PT – “Advances in Pediatric Outcomes: Neuromodulation and Rehabilitation: Past, Through COVID-19, and Beyond”
March 5 @ 12:00 pm - 1:00 pm
Bernadette Gillick, PhD, MSPT, PT
About the Speaker: Dr. Gillick earned her PhD in Rehabilitation Science with a minor in Neuroscience from the University of Minnesota, and completed a fellowship in Randomized Behavioral Clinical Trials at the National Institutes of Health. She is currently a tenured Associate Professor at the University of Minnesota Medical School. She is an internationally respected expert on the use of innovative technologies and interventions in perinatal stroke and cerebral palsy from infancy to young adulthood. Her current grant support includes an NIH R01 and R21, investigating cortical and behavioral development after perinatal stroke and early brain injury using non-invasive brain stimulation and neuroimaging.
|In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.
American Psychological Association (APA)
|Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.|
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
Continuing Education Disclosures
|Name||Role||Financial Relationship Disclosures||Discussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
|HAYLEY CRAIN||Planner||No relevant financial relationships to disclose||No|
|Carly Eichten||Planner||No relevant financial relationships to disclose||No|
|Manda Ratcliff||Planner||No relevant financial relationships to disclose||No|
|Eric Schafer||Planner||No relevant financial relationships to disclose||No|
|DANIELLE SCHOLZE||Planner||No relevant financial relationships to disclose||No|
|EMILY SCHUMACHER||Planner||No relevant financial relationships to disclose||No|
|MARIA STANLEY||Course Director||Octapharma USA, Inc. (Contractor),
Takeda Development Center Americas, Inc. (Contractor)
|BERNADETTE GILLICK||Speaker/Author||No relevant financial relationships to disclose||No|
For Further Information: Contact Teresa Palumbo at 608.263.5837 or email@example.com
The seminar series is funded by the John D. Wiley Conference Center Fund, the Friends of the Waisman Center and NIH grant U54 HD090256.
Zoom Information: To obtain the Zoom link for this seminar contact Clark Kellogg at firstname.lastname@example.org
This seminar is limited to 300 participants.